Further signs that the biotech initial public offering (IPO) market is picking up have come with a filing by MBX Biosciences, seeking around $100 million to take a hypoparathyroidism candidate into ...

Choosing a pistol-caliber carbine is less about brand loyalty and more about how you actually plan to use it.... The post 9mm vs 10mm vs .45 ACP: picking the right PCC caliber appeared first on The ...

One-year follow-up data from Phase 2 trial of once-weekly canvuparatide, a potential best-in-class therapy for hypoparathyroidism, anticipated in Q2 2026; Phase 3 initiation on track for Q3 2026 ...

Fintel reports that on January 7, 2026, UBS initiated coverage of MBX Biosciences (NasdaqGS:MBX) with a Buy recommendation. Analyst Price Forecast Suggests 110.57% Upside As of December 21, 2025, the ...

Great. Good afternoon, everyone. Welcome. My name is Jess Fye. I'm a biotech analyst at JPMorgan, and we're continuing our 44th Annual Healthcare Conference today with MBX. First, you're going to hear ...

Investing.com - Stifel has reiterated its Buy rating and $50.00 price target on MBX Biosciences Inc (NASDAQ:MBX), highlighting the company’s aggressive advancement of its obesity drug portfolio with a ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

More outdoorspeople are carrying a handguns than ever before these days, both for personal protection and for protection against dangerous critters in the woods. When it comes to choosing a sidearm, ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. Chart does not reflect ...